Molecular Cardiovascular Biology
Faculty Labs

Faculty Labs

See developments of our faculty labs in the Division of Molecular Cardiovascular Biology at Cincinnati Children's.

Labs (8)

ACTIVELY RECRUITING Ikegami Lab

Our Focus/Goals

Our lab studies how nuclear envelope function and chromosome organization influence cardiovascular disease, aging, and lamin-related disorders to better understand disease mechanisms and identify therapeutic targets.

Learn More
Liu Lab

Our Focus/Goals

Our lab studies the molecular mechanisms of cardiac injury and remodeling to develop gene therapy strategies that promote heart repair and improve heart function after injury.

Learn More
Makarewich Lab

Our Focus/Goals

Our lab studies the molecular mechanisms of cardiovascular and skeletal muscle disease, with a focus on microproteins, to uncover new biology and develop targeted therapies.

Learn More
ACTIVELY RECRUITING Millay Lab

Our Focus/Goals

Our lab studies skeletal muscle development, regeneration, and cell fusion to better understand muscle function, aging, and disease and to develop new therapeutic approaches.

Learn More
ACTIVELY RECRUITING Molkentin Lab

Our Focus/Goals

Our lab studies the molecular and cellular mechanisms of heart and skeletal muscle disease to identify new therapeutic targets related to cell death, signaling, remodeling, and muscle function.

Learn More
Steimle Lab

Our Focus/Goals

Our lab investigates gene-regulatory networks, with a focus on the transcription factor PITX2, to understand how developmental programs are controlled and to identify therapeutic targets for diseases such as cardiac arrhythmias.

Learn More
ACTIVELY RECRUITING Waxman Lab

Our Focus/Goals

Our lab studies how cardiac progenitor cell selection and signaling pathways regulate heart development to better understand congenital heart defects and improve strategies for cardiac regeneration and repair.

Learn More
Yutzey Lab

Our Focus/Goals

Our lab studies the molecular regulatory mechanisms that control heart development and disease, with the goal of identifying how developmental signaling pathways are reactivated in cardiovascular disease and can be targeted for therapy.

Learn More